Answer
It is contraindicated with moderate-to-severe renal impairment or severe hepatic impairment. Milder impairment requires prescriber assessment and closer monitoring.
Sources for this answer
- Skudexa 75 mg/25 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.